Confidence and perceptions toward deprescribing among PharmD students in Saudi Arabian Universities

Main Article Content

Khalid A. Alamer

Keywords

Deprescribing;, PharmD students;, Pharmacy education;, Saudi Arabia;, Medication safety; , Confidence; , Perception;, Curriculum

Abstract

Background: Deprescribing is an essential patient safety process that remains underrepresented in pharmacy curricula. While many students may hold favorable perceptions toward deprescribing, their confidence in applying it in practice is often limited. In Saudi Arabia, there is limited data on the perceptions and confidence of PharmD students regarding deprescribing. Objective: To evaluate the confidence, perception, and educational exposure toward deprescribing among Saudi PharmD students across all professional years. Methods: A national cross-sectional survey was distributed using a convenience sampling approach. The instrument included demographic variables and two validated Likert scales measuring deprescribing confidence (5 items) and perception (8 items). Descriptive and multivariate analyses were conducted to investigate predictors of confidence and willingness to participate in deprescribing training. Results: A total of 253 PharmD students completed the questionnaire. While 70% were familiar with the concept of deprescribing, confidence remained moderate overall (mean: 3.26 ± 1.05), despite high perception scores (3.92 ± 1.05). Confidence increased significantly from P3 to P4 (2.62 vs. 3.73; p < 0.001). Multivariable analysis showed that confidence was the sole independent predictor of workshop enrollment (AOR = 0.66; 95% CI: 0.44–0.98; p = 0.04), even after adjusting for course exposure and perception. Conclusion: Although Saudi PharmD students have a positive perception of deprescribing, their confidence and intention to implement it in practice are lacking. A common trend observed in international research is that deprescribing is neither introduced early enough nor discussed frequently enough in pharmacy school curricula. National educational leaders are urged to integrate deprescribing competencies into core curricular frameworks, particularly within geriatrics and interprofessional learning, to align students’ perceptions with their practical application.

Abstract 64 | PDF Downloads 37

References

1. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. doi:10.1186/s12877-017-0621-2.
2. Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12(3):443-452. doi:10.1007/s41999-021-00479-3.
3. Wastesson JW, Morin L, Tan ECK, Johnell K. Clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185-1196. doi:10.1080/14740338.2018.1546841.
4. O’Mahony D, Cherubini A, Guiteras AR, Denkinger M, Beuscart JB, Onder G, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14(4):625-632. doi:10.1007/s41999-023-00777-y.
5. Oktora MP, Alfian SD, Bos HJ, Schuiling-Veninga CCM, Taxis K, Hak E, Denig P. Trends in polypharmacy and potentially inappropriate medication in people treated for diabetes. Br J Clin Pharmacol. 2021;87(7):2807-2817. doi:10.1111/bcp.14685.
6. Kim S, Lee H, Park J, Kang J, Rahmati M, Rhee SY, Yon DK. Global and regional prevalence of polypharmacy and related factors: an umbrella review. Arch Gerontol Geriatr. 2024;124:105465. doi:10.1016/j.archger.2024.105465.
7. World Health Organization. Medication without harm: policy brief. Geneva: WHO; 2024.
8. Ibrahim K, Cox NJ, Stevenson JM, Lim S, Fraser SDS, Roberts HC. Deprescribing interventions among older people living with frailty: a systematic review. BMC Geriatr. 2021;21(1):258. doi:10.1186/s12877-021-02208-8.
9. Thompson W, McDonald EG. Polypharmacy and deprescribing in older adults. Annu Rev Med. 2024;75:113-127. doi:10.1146/annurev-med-070822-101947.
10. Carollo M, Crisafulli S, Vitturi G, Besco M, Hinek D, Sartorio A, et al. Clinical impact of medication review and deprescribing in older inpatients: a systematic review and meta-analysis. J Am Geriatr Soc. 2024;72(10):3219-3238. doi:10.1111/jgs.19035.
11. Campbell NL, Pitts C, Corvari C, Kaehr E, Alamer K, Chand P, et al. Deprescribing anticholinergics in primary care older adults. J Am Coll Clin Pharm. 2022;5(10):1039-1047. doi:10.1002/jac5.1682.
12. Gonçalves JR, Magalhães N, Machado S, Ramalhinho I, Cavaco AM. Pharmacist-mediated deprescribing in long-term care facilities: a systematic review. Pharmacy (Basel). 2025;13(1):3. doi:10.3390/pharmacy13010003.
13. Alamer KA, Holden RJ, Chui MA, Stone JA, Campbell NL. Home medication inventory method to assess OTC medication possession and use. Res Social Adm Pharm. 2024;20(4):443-450. doi:10.1016/j.sapharm.2024.01.005.
14. Campbell NL, Holden RJ, Gao S, Unverzagt FW, Lane KA, Carter A, et al. Deprescribing anticholinergics to preserve brain health: R2D2 randomized clinical trial protocol. Trials. 2024;25(1):788. doi:10.1186/s13063-024-08618-4.
15. Abebe E, Campbell NL, Clark DO, Tu W, Hill JR, Harrington AB, et al. Reducing anticholinergic medication exposure using consumer technology: protocol for a randomized clinical trial. Res Social Adm Pharm. 2021;17(5):986-992. doi:10.1016/j.sapharm.2020.10.010.
16. Vision 2030 Kingdom of Saudi Arabia. Health Sector Transformation Program: Delivery Plan 2020–2021. Riyadh: Vision 2030; 2021.
17. Alaa Eddine N, Schreiber J, El-Yazbi AF, Shmaytilli H, Amin MEK. Pharmacist-led medication review service with a deprescribing focus. Front Pharmacol. 2023;14:1097238. doi:10.3389/fphar.2023.1097238.
18. Bužančić I, Kummer I, Držaić M, Ortner Hadžiabdić M. Community-based pharmacists’ role in deprescribing: a systematic review. Br J Clin Pharmacol. 2022;88(2):452-463. doi:10.1111/bcp.14947.
19. American College of Clinical Pharmacy. ACCP Pharmacotherapy Didactic Curriculum Toolkit—2019 update. Lenexa (KS): ACCP; 2019.
20. International Pharmaceutical Federation (FIP). Development Goal 7: Advancing integrated services. The Hague: FIP.
21. Poots AJ, Jubraj B, Ward E, Wycoco A, Barnett N. Education around medication review and deprescribing: perspectives of medical and pharmacy students. Ther Adv Drug Saf. 2020;11:2042098620909610. doi:10.1177/2042098620909610.
22. Clark CM, Hejna M, Shao E, Maerten-Rivera JL, Monte SV, Wahler RG Jr. Knowledge and attitudes of student pharmacists regarding polypharmacy and deprescribing. Pharmacy (Basel). 2020;8(4):220. doi:10.3390/pharmacy8040220.
23. Al Omari SM, Alhamad H, Barakat M, Sawan HM, Mecca MC, Al Bahar F. Attitudes and perceptions of Jordanian pharmacy students toward deprescribing. Pharm Pract. 2023;21(2).
24. Fathelrahman AI, Alrobaian M, Altowayan WM, Maghrabi I, Asiri YA. Pharmacy education in Saudi Arabia: achievements and challenges. Saudi Pharm J. 2022;30(6):649-654. doi:10.1016/j.jsps.2022.04.001.
25. AlRuthia Y, Alsenaidy MA, Alrabiah HK, AlMuhaisen A, Alshehri M. Status of licensed pharmacy workforce in Saudi Arabia. Hum Resour Health. 2018;16(1):28. doi:10.1186/s12960-018-0294-8.
26. Almaghaslah D, Alsayari A, Almanasef M, Asiri A. Pharmacy students’ career choices in light of Saudi Vision 2030. Int J Environ Res Public Health. 2021;18(9):4589. doi:10.3390/ijerph18094589.
27. Bawazeer GA, Alqifari SF, Alkhudair NA, Aldemerdash AF, Aljuffali LA, Korayem GB. The 2024 Saudi Pharmacotherapy Didactic Curriculum Toolkit. BMC Med Educ. 2025;25(1):583. doi:10.1186/s12909-025-07129-3.
28. American Geriatrics Society Beers Criteria® Update Expert Panel. AGS 2023 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081. doi:10.1111/jgs.18372.
29. National Center for Academic Accreditation and Evaluation (NCAAA). Jahiziyah Program Learning Outcomes Framework. Riyadh: Education and Training Evaluation Commission; 2024.
30. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827-834. doi:10.1001/jamainternmed.2015.0324.
31. Papillon-Ferland L, Ben Abdelkader L, Maurice N, Choinière A, Awwad Y, Aredjian R, et al. Geriatric education for pharmacy students: a scoping review. J Am Geriatr Soc. 2025;73(3):930-946. doi:10.1111/jgs.19215.
32. Alotaibi F. Knowledge and attitude of pharmacy students regarding geriatric care and elderly in Saudi Arabia. Pharm Pract. 2025;23(1):1-5.
33. AlRuthia Y, Bashatah A, Batis AA, Alradhi SA, Almohammed O, Sales I, et al. Opportunities and challenges to implementing interprofessional education in Saudi Arabia. J Interprof Care. 2023;37(1):47-57. doi:10.1080/13561820.2021.2004097.
34. McLachlan JC, Auta A, Ajiboye A. Assessment and evaluation of prescribing competences: a systematic review. Br J Clin Pharmacol. 2025;91(8):2119-2137. doi:10.1111/bcp.16033.
35. Barnes KN, Hardinger KL, Graham MR. Review of objective structured clinical examination practices within pharmacy programs in the United States. Am J Pharm Educ. 2024;88(4):100686. doi:10.1016/j.ajpe.2024.100686.
36. Clark C, Maerten-Rivera J, Prescott W, Doloresco F, Wahler R. Flipped-classroom approach to teach deprescribing and safe medication use in geriatric pharmacotherapy. Pharm Educ. 2023;23(1):307-313.
37. Chowdhury S, Mok D, Leenen L. Transformation of healthcare and the new model of care in Saudi Arabia: Vision 2030. J Med Life. 2021;14(3):347-354. doi:10.25122/jml-2021-0070.
38. Alghamdi AA. Medication safety in Saudi Arabia: evaluating the current situation and identifying areas for improvement. Pharmacy (Basel). 2025;13(2):50. doi:10.3390/pharmacy13020050.